Guardion Health Sciences
Guardion Health Sciences is at the forefront of early detection, intervention and monitoring of a range of eye diseases. The company combines targeted ocular nutrition with innovative evidence-based diagnostic technology. Located in San Diego, Guardion boasts one of the most impressive Scientific and Medical Advisory Boards in the world. This combination of expertise and scientific knowledge has catapulted Guardion into a leadership position within the eye care industry. Further, the company is led by seasoned business executives with many years of experience in running and expanding public companies.
Lumega-Z has been used clinically since 2012. Typical symptoms of these patients included poor night vision, higher sensitivity to glare and overall reduction in vision for everyday activities, like driving or playing golf. Patients also experienced medical symptoms, such as appearance of drusen in the retina.
Patient results show that Lumega-Z not only can slow the progression of vision loss associated with a depleted macular pigment and macular degeneration in many patients, in some cases, Lumega-Z has reversed vision loss. These videos are comments from real patients who have been treated with Lumega-Z and whose vision has stabilized or improved.
Guardion Health Sciences, the maker of Lumega-Z, cannot guarantee the same results as these patients for vision improvement or any vision benefit with treatment.